Form 4 for VOR Vor Biopharma Inc.
Accepted 2025-05-02 00:00:00 ET · period of report 2025-05-01 · accession 0001415889-25-011803 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-02 | 2025-05-01 | VOR | ANG ROBERT | Pres AND CEO, Dir | F - Tax | $0.66 | -5,273 | 913.7K | -0.6% | -$3,480 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-01 | F | D | 2,751 | $0.66 | 916,201 | D | — | — | (F1) Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. |
| 2 | Common | Common Stock | 2025-05-01 | F | D | 2,522 | $0.66 | 913,679 | D | — | — | (F1) Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. |